Limitations of the obstetric group B Streptococcus protocol

Area of Science:

• Obstetrics and Gynecology
• Infectious Disease Prevention
• Public Health Protocols

Background:

• Group B Streptococcus (GBS) poses a significant risk during pregnancy and childbirth.
• The Centers for Disease Control and Prevention (CDC) established a screening-based protocol to mitigate GBS transmission risks.
• Adherence to established GBS screening and treatment protocols is crucial for maternal and neonatal health.

Purpose of the Study:

• To evaluate adherence to the CDC's GBS screening protocol in an obstetric community clinic setting.
• To identify specific areas of non-compliance within the GBS protocol.
• To determine a potential acceptable threshold for protocol failure, considering various influencing factors.

Main Methods:

• A retrospective chart review of 248 deliveries at a resident-run community clinic from January to June 1999.
• Assessment of compliance by comparing patient chart data against CDC protocol requirements.
• Collection of data on demographics, GBS status, gestational age at screening, timing of membrane rupture, antibiotic administration, and delivery.

Main Results:

• Overall compliance was 70% for GBS culture collection and 87% for treatment.
• Significant deviations included cultures collected outside recommended gestational windows (17.5% before 35 weeks, 12.6% after 37 weeks).
• Treatment failures occurred in 7.0% of known positive GBS cases and 24.5% received antibiotics less than four hours before delivery.

Conclusions:

• Fulfillment of CDC GBS guidelines in this community setting was imperfect.
• Factors such as precipitous delivery and patient non-compliance present challenges to protocol adherence.
• Further analysis may help establish an acceptable threshold for deviations from the GBS protocol.